Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$1.18 - $2.04 $15,635 - $27,030
-13,250 Closed
0 $0
Q1 2022

Apr 19, 2022

SELL
$1.34 - $2.26 $1,072 - $1,807
-800 Reduced 5.69%
13,250 $25,000
Q4 2021

Jan 21, 2022

BUY
$2.1 - $4.36 $7,872 - $16,345
3,749 Added 36.39%
14,050 $30,000
Q2 2021

Jul 28, 2021

SELL
$4.85 - $6.9 $7,274 - $10,350
-1,500 Reduced 12.71%
10,301 $55,000
Q1 2021

Apr 27, 2021

BUY
$6.09 - $12.2 $71,868 - $143,972
11,801 New
11,801 $79,000
Q4 2020

Jan 26, 2021

SELL
$3.56 - $10.21 $37,390 - $107,235
-10,503 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$2.49 - $5.16 $26,152 - $54,195
10,503 New
10,503 $47,000
Q1 2020

Apr 29, 2020

SELL
$1.52 - $2.66 $25,099 - $43,924
-16,513 Closed
0 $0
Q4 2019

Jan 14, 2020

SELL
$2.0 - $2.64 $4,000 - $5,280
-2,000 Reduced 10.8%
16,513 $42,000
Q3 2019

Oct 15, 2019

BUY
$2.5 - $3.93 $7,485 - $11,766
2,994 Added 19.29%
18,513 $43,000
Q2 2019

Aug 05, 2019

BUY
$1.96 - $3.21 $3,912 - $6,407
1,996 Added 14.76%
15,519 $51,000
Q4 2018

Feb 19, 2019

BUY
$1.68 - $3.44 $22,718 - $46,519
13,523 New
13,523 $33,000

Others Institutions Holding AQB

About AquaBounty Technologies, Inc.


  • Ticker AQB
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Farm Products
  • Shares Outstandng 71,110,704
  • Market Cap $51.2M
  • Description
  • AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...
More about AQB
Track This Portfolio

Track Pfg Advisors Portfolio

Follow Pfg Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Advisors with notifications on news.